Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: A new therapeutic strategy

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2714-2725

  Rüller, Stephan ^a   Stahl, Christian ^a   Köhler, Gotje ^a   Eickhoff, Bodo ^a   Breder, Jörg ^a,b   Schlaak, Max ^a   Van Der Bosch, Jürgen ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; BUCLADESINE; BUTYRIC ACID; CASPASE INHIBITOR; EPIDERMAL GROWTH FACTOR; FLAVOPIRIDOL; STRESS ACTIVATED PROTEIN KINASE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MODEL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR RESISTANCE;

ANIMALS; ANISOMYCIN; ANTINEOPLASTIC AGENTS; APOPTOSIS; BUCLADESINE; EPIDERMAL GROWTH FACTOR; FLAVONOIDS; HUMANS; HYDROXAMIC ACIDS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS, EXPERIMENTAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PIPERIDINES; TUMOR CELLS, CULTURED;

EID: 0344199996     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
2. Hickman, J. A. Apoptosis and chemotherapy resistance. Eur. J. Cancer, 32A: 921-926, 1996.
3. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
4. Sorger, P. K., Dobles, M., Tournebize, R., and Hyman, A. A. Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol., 9: 807-814, 1997.
5. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. When checkpoints fail. Cell, 88: 315-321, 1997.
6. Lewis, T. S., Shapiro, P. S., and Ahn, N. G. Signal Transduction through MAP kinase cascades. Adv. Cancer Res., 74: 49-139, 1998.
7. Cohen, P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol., 7: 353-361, 1997.
8. Kyriakis, J., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Liu, F., and Woodgett, J. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol., 6: 606-613, 1996.
9. 2-terminal kinase (JNK/SAPK). J. Biol. Chem., 43: 28253-28260, 1998.
10. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. MEKK/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA, 18: 10541-10546, 1998.
11. Wang, T-H., Wang, H-S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalasena, J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem., 273: 4928-4936, 1998.
12. Liu, Z-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., and Wang, J. Y. J. Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature (Lond.), 384: 273-276, 1996.
13. 2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J. Biol. Chem., 271: 30950-30955, 1996.
14. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., and Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem., 272: 14041-14044, 1997.
15. Takenaka, K., Moriguchi, T., and Nishida, E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science (Washington DC), 280: 599-602, 1998.
16. 2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem., 272: 4631-4636, 1997.
17. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature (Lond.), 392: 300-303, 1998.
18. Waldmann, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
19. Kung, A. L., Zetterberg, A., Sherwood, S. W., and Schimke, R. T. Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res., 50: 7307-7317, 1990.
20. Schimke, R. T., Kung, A. L., Sherwood, S. W., Sheridan, J., and Sharma, R. Life, death and genomic change in perturbed cell cycles. Phil. Trans. R. Soc. Lond. B Biol. Sci., 345: 311-317, 1994.
21. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Ruble, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
22. Hazzalin, C. A., Cano, E., Cuenda, A., Barratt, M. J., Cohen, P., and Mahadevan, L. C. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr. Biol., 6: 1028-1031, 1996.
23. Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T-H., Pearson, J. A., Chen, S. L. Y., and Magun, B. E. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Mol. Cell. Biol., 17: 3373-3381, 1997.
24. Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T-H., Pearson, J. A., and Magun, B. E. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem., 273: 15794-15803, 1998.
25. van der Bosch, J., Rüller, E., Ernst, M., Schade, U. F., Mathison, J. C., Rüller, S., and Schlaak, M. Cytokines involved in monocyte mediated tumor cell death and growth inhibition in serum-free medium. J. Cell. Physiol., 152: 617-625, 1992.
26. Yoshida, M., Kijima, M., Akita, M., and Beppu, T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265: 17174-17179, 1990.
27. Yoshida, M., Horinouchi, S., and Beppu, T. Trichostatin A and trapoxin: novel chemical probes for the role of histone deacetylation in chromatin structure and function. BioEssays, 17: 423-430, 1995.
28. 1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
29. Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., and Worland, P. J. Potent inhibition of Cdc2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 201: 589-595, 1994.
30. Krupitza, G., Grill, S., Harant, H., Hulla, W., Szekeres, T., Huber, H., and Dittrich, C. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. Br. J. Cancer, 73: 433-438, 1996.
31. Gupta, S., Alpini, G., Vemuru, R. P., Hurston, E., and Shafritz, D. A. Butyrate synchronization of hepatocytes: modulation of cycling and cell cycle regulated gene expression. Growth Factors, 10: 171-180, 1994.
32. Barnard, J. A., and Warlock, G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ., 4: 495-501, 1993.
33. Toscani, A., Soprano, D. R., and Soprano, K. J. Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res., 3: 223-238, 1988.
34. wafl is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA, 95: 6791-6796, 1998.
35. Sommer, A., Hilfenhaus, S., Menkel, A., Kremmer, E., Seiser, C., Loidl, P., and Lüscher, B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol., 7: 357-365, 1997.
36. L expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis. Radiat. Res., 149: 187-194, 1998.
37. Bible, K. C., and Kaufmann, S. H. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration. Cancer Res., 57: 3375-3380, 1997.
38. Bible, K. C., and Kaufmann, S. H. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. Cancer Res., 56: 4856-4861, 1996.
39. Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., and Sausville, E. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst., 84: 1736-1740, 1992.
40. Senderowicz, A. M., Headlee, D., Stinson, S., Lush, R. M., Kalil, N., Villalba, L., Hill, K., Steinberg, S. M., Figg, W. D., Tomkins, A., Arbuck, S. G., and Sausville, E. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase with refractory neoplasm. J. Clin. Oncol., 9: 2986-2999, 1998.
41. 2. Exp. Cell Res., 223: 259-267, 1996.
42. Stryer, L. Biochemistry, Ed. 3, p. 717. New York: W. H. Freeman, 1988.
43. Mashima, T., Naito, M., Kataoka, S., Kawai, H., and Tsuruo, T. Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. Biophys. Res. Commun., 209: 907-915, 1995.
44. Levitzki, A., and Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science (Washington DC), 267: 1782-1788, 1995.
45. Ui, M., Okada, T., Hazeki, K., and Hazeki, O. Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem. Sci., 20: 303-307, 1995.
46. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
47. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEES Lett., 364: 229-233, 1995.
48. Whitmarsh, A. J., Yang, S-H., Su, M. S. S., Sharrocks, A. D., and Davis, R. J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol., 17: 2360-2371, 1997.
49. Karin, M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. NY Acad. Sci., 851: 139-146, 1998.
50. Widmann, C., Gerwins, P., Johnson, N. L., Jarpe, M. B., and Johnson, G. L. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol., 18: 2416-2429, 1998.
51. Paul, A., Wilson, S., Belham, C. M., Robinson, C. J. M., Scott, P. H., Gould, G. W., and Plevin, R. Stress-activated protein kinases: activation, regulation and function. Cell. Signal., 9: 403-410, 1997.
52. Zinck, R., Cahill, M. A., Kracht, M., Sachsenmaier, C., Hipskind, R. A., and Nordheim, A. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol., 15: 4930-4938, 1995.
53. Park, J., Kim, I., Oh, Y. J., Lee, K., Han, P. L., and Choi, E. J. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2. J. Biol. Chem., 272: 16725-16728, 1997.
54. Villa, P., Kaufmann, S. H., and Earnshaw, W. C. Caspases and caspase inhibitors. Trends Biochem. Sci., 22: 388-393, 1997.
55. Widmann, C., Gibson, S., and Johnson, G. L. Caspase-dependent cleavage of signaling proteins during apoptosis. J. Biol. Chem., 273: 7141-7147, 1998.
56. Wyllie, A., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
57. Wolffe, A. P. Histone deacetylase: a regulator of transcription. Science (Washington DC), 272: 371-372, 1996.
58. Davie, J. R. Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol. Biol. Rep., 24: 197-207, 1997.
59. Mandal, M., and Kumar, R. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ., 7: 311-318, 1996.
60. McBain, J. A., Eastman, A., Nobel, C. S., and Mueller, G. C. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol., 53: 1357-1368, 1997.
61. Medina, V., Edmonds, B., Young, G. P., James, R., Appleton, S., and Zalewski, P. D. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with mitochondrial/cytochrome c-dependent pathway. Cancer Res., 57: 3697-3707, 1997.
62. Garcia-Bermejo, L., Vilaboa, N. E., De Blas, E., Calle, C., and Aller, P. Modulation of HSP70 and HSP27 gene expression by the differentiation inducer sodium butyrate in U-937 human promonocytic leukemia cells. Leuk. Res., 19: 713-718, 1995.
63. Garcia-Bermejo, L., Viloba, N. E., Perez, C., Galan, A., De Blas, E., and Aller, P. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis. Exp. Cell Res., 236: 268-274, 1997.
64. Brown, E. J., and Schreiber, S. L. A signaling pathway to translational control. Cell, 86: 517-520, 1996.
65. Franke, T. F., Kaplan, D. R., and Cantley, L. C. PI3K: downstream AKTion blocks apoptosis. Cell, 88: 435-437, 1997.
66. Alessi, D. R., and Cohen, P. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev., 8: 55-62, 1998.
67. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241, 1997.
68. L. Cell, 87: 619-628, 1996.
69. L and Bcl-2, displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
70. L, and Apaf-1 form a ternary complex. J. Biol. Chem., 273: 5841-5845, 1998.
71. Hu, Y., Benedict, M., Dayang, W., Inohara, N., and Nuñez, G. BCLXL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA, 95: 4386-4391, 1998.
72. L through caspase interaction. Proc. Natl. Acad. Sci. USA, 95: 554-559, 1998.
73. Sable, C. L., Filippa, N., Hemmings, B., and van Obberghen, E. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEES Lett., 409: 253-257, 1997.
74. Wang, H-G., Rapp, U. R., and Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87: 629-638, 1996.